Disease: Malignant neoplasm of lung
Source: INFERRED ×
Variant Gene DSI v DPI v Chr Position Consequence Alleles Class AF EXOME AF GENOME Num. diseases
rs1394371 0.925 0.080 15 78432127 intergenic variant C/T snv 0.22 4
rs1794282 0.807 0.320 6 32698749 intergenic variant C/T snv 6.4E-02 6
rs2746150 0.851 0.240 6 29474924 downstream gene variant C/T snv 5.3E-02 4
rs3094054 0.807 0.280 6 30365728 upstream gene variant G/A;T snv 6
rs3129763 0.827 0.280 6 32623148 TF binding site variant G/A snv 0.23 6
rs3130350 0.827 0.280 6 30360062 upstream gene variant G/T snv 7.1E-02 5
rs3130544 0.807 0.360 6 31090563 intergenic variant C/A snv 7.4E-02 10
rs3130893 0.882 0.160 6 29012930 intergenic variant A/G snv 5.3E-02 3
rs4324798 0.790 0.240 6 28808340 intergenic variant G/A snv 7.2E-02 5
rs4635969 0.827 0.160 5 1308437 downstream gene variant G/A;T snv 5
rs4887053 0.925 0.080 15 78420357 regulatory region variant A/C;T snv 4
rs4975616 0.763 0.320 5 1315545 downstream gene variant G/A snv 0.51 5
rs3132610
ABCF1
0.807 0.280 6 30576624 intron variant A/G snv 7.4E-02 6
rs3117582
BAG6 ; APOM
0.716 0.440 6 31652743 intron variant T/G snv 7.1E-02 8
rs11571833
BRCA2
0.608 0.360 13 32398489 stop gained A/T snv 6.6E-03 6.0E-03 21
rs558702
C2 ; ZBTB12 ; CYP21A2
0.807 0.320 6 31902549 intron variant G/A snv 7.7E-02 6
rs1270942
CFB ; CYP21A2
0.742 0.440 6 31951083 non coding transcript exon variant A/G snv 7.5E-02 7
rs1051730
CHRNA3
0.641 0.600 15 78601997 synonymous variant G/A snv 0.27 0.26 11
rs12910984
CHRNA3
0.827 0.080 15 78599285 intron variant G/A;C;T snv 4
rs12914385
CHRNA3
0.790 0.160 15 78606381 intron variant C/A;T snv 13
rs578776
CHRNA3
0.742 0.240 15 78596058 3 prime UTR variant G/A snv 0.39 3
rs8042374
CHRNA3
0.807 0.200 15 78615690 intron variant A/G snv 0.29 9
rs938682
CHRNA3
0.851 0.080 15 78604205 intron variant G/A snv 0.72 5
rs6495306
CHRNA5
0.925 0.080 15 78573551 intron variant G/A;C snv 2
rs680244
CHRNA5
0.882 0.120 15 78578946 intron variant T/C snv 0.60 2